Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?

This publication has 48 references indexed in Scilit:

• Prognostic Value of Tumor-associated Macrophages Count in Human Non-muscle-invasive Bladder Cancer Treated by BCG Immunotherapy
  Ultrastructural Pathology, 2013
• The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
  PLOS ONE, 2012
• Guía clínica del carcinoma urotelial de vejiga no músculo-invasivo de la Asociación Europea de Urología. Actualización de 2011
  Actas Urológicas Españolas, 2012
• International Variation in Prostate Cancer Incidence and Mortality Rates
  European Urology, 2012
• Prospective Study of Trichomonas vaginalis Infection and Prostate Cancer Incidence and Mortality: Physicians' Health Study
  JNCI: Journal of the National Cancer Institute, 2009
• TLR-mediated immune responses in the urinary tract
  Current Opinion in Microbiology, 2008
• Plasma Antibodies against Chlamydia trachomatis, Human Papillomavirus, and Human Herpesvirus Type 8 in Relation to Prostate Cancer: A Prospective Study
  Cancer Epidemiology, Biomarkers & Prevention, 2007
• PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata
  Cancer, 2007
• Estimates of the cancer incidence and mortality in Europe in 2006
  Annals of Oncology, 2007
• Inflammation and cancer
  Nature, 2002